Yuhan Xie

ORCID: 0000-0002-1738-0885
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Genetic Associations and Epidemiology
  • Genomics and Rare Diseases
  • Genomic variations and chromosomal abnormalities
  • Bioinformatics and Genomic Networks
  • Metabolism and Genetic Disorders
  • Congenital heart defects research
  • RNA modifications and cancer
  • Molecular Biology Techniques and Applications
  • Genetic factors in colorectal cancer
  • Folate and B Vitamins Research
  • Vitamin D Research Studies
  • Protein Structure and Dynamics
  • Statistical Methods in Clinical Trials
  • Fibroblast Growth Factor Research
  • BRCA gene mutations in cancer
  • Epigenetics and DNA Methylation
  • Colorectal Cancer Treatments and Studies
  • Cancer Genomics and Diagnostics
  • Genomics and Phylogenetic Studies
  • Lipoproteins and Cardiovascular Health
  • Erythrocyte Function and Pathophysiology
  • Salivary Gland Disorders and Functions
  • Metabolomics and Mass Spectrometry Studies
  • Genetic Syndromes and Imprinting
  • RNA and protein synthesis mechanisms

Yale University
2021-2025

Duke Kunshan University
2025

Zhishan Chen Xingyi Guo Ran Tao Jeroen R. Huyghe Philip Law and 95 more Ceres Fernández‐Rozadilla Jie Ping Guochong Jia Jirong Long Chao Li Quanhu Shen Yuhan Xie Maria Timofeeva Minta Thomas Stephanie L. Schmit Virginia Díez‐Obrero Matthew A.M. Devall Ferrán Moratalla-Navarro Juan Fernández‐Tajes Claire Palles Kitty Sherwood Sarah Briggs Victoria Svinti Kevin Donnelly Susan M. Farrington James P. Blackmur P G Vaughan-Shaw Xiao‐Ou Shu Yingchang Lu Peter Broderick James B. Studd Tabitha A. Harrison David V. Conti Fredrick R. Schumacher Marilena Melas Gad Rennert Mireia Obón‐Santacana Vicente Martín Jae Hwan Oh Jeongseon Kim Sun Ha Jee Keum Ji Jung Sun-Seog Kweon Min‐Ho Shin Aesun Shin Yoon‐Ok Ahn Dong-Hyun Kim Isao Oze Wanqing Wen Keitaro Matsuo Koichi Matsuda Chizu Tanikawa Zefang Ren Yu‐Tang Gao Wei‐Hua Jia John L. Hopper Mark A. Jenkins Aung Ko Win Rish K. Pai Jane C. Figueiredo Robert W. Haile Steven Gallinger Michael O. Woods Polly A. Newcomb David Duggan Jeremy P. Cheadle Richard Kaplan Rachel Kerr David Kerr Iva Kirac Jan Böhm Jukka‐Pekka Mecklin Pekka Jousilahti Paul Knekt Lauri A. Aaltonen Harri Rissanen ­Eero Pukkala Johan G. Eriksson Tatiana Cajuso Ulrika A. Hänninen Johanna Kondelin Kimmo Palin Tomas Tanskanen Laura Renkonen‐Sinisalo Satu Männistö Demetrius Albanes Stephanie J. Weinstein Edward A. Ruiz‐Narváez Julie R. Palmer Daniel D. Buchanan Elizabeth A. Platz Kala Visvanathan Cornelia M. Ulrich Erin M. Siegel Stefanie Brezina Andrea Gsur Peter T. Campbell Jenny Chang‐Claude Michael Hoffmeister Hermann Brenner

Abstract Genome-wide association studies (GWAS) have identified more than 200 common genetic variants independently associated with colorectal cancer (CRC) risk, but the causal and target genes are mostly unknown. We sought to fine-map all known CRC risk loci using GWAS data from 100,204 cases 154,587 controls of East Asian European ancestry. Our stepwise conditional analyses revealed 238 independent signals each a set credible (CCVs), which 28 had single CCV. cis-eQTL/mQTL colocalization...

10.1038/s41467-024-47399-x article EN cc-by Nature Communications 2024-04-26

Reelin and sphingosine-1-phosphate (S1P) are important in adult neurogenesis, particularly the repositioning of newly formed dentate granule cells (DGCs). The relationship between S1P new DGCs is investigated this study, with a specific focus on their functioning pathways upstream/downstream relationships. Applying gene knockdown immunostaining methods, research discovers that function same signaling pathway during DGC's process, it appears works upstream S1P. results could potentially...

10.54254/2753-8818/2024.19363 article EN cc-by Theoretical and Natural Science 2025-01-08

Identifying genes associated with rare diseases remains challenging due to the scarcity of patients and limited statistical power traditional association methods. Here, we introduce PERADIGM (Phenotype Embedding Similarity-based Rare Disease Gene Mapping), a novel framework that leverages natural language processing techniques integrate comprehensive phenotype information from electronic health records for disease gene discovery. employs an embedding model capture relationships between...

10.1101/2025.04.01.646670 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2025-04-07

Ischemic stroke (IS) is a highly heritable trait, and genome-wide association studies have identified several commonly occurring susceptibility risk loci for this condition. However, there are limited data on the contribution of rare genetic variation to IS.

10.1161/strokeaha.122.040883 article EN Stroke 2023-02-10

De novo variants (DNVs) with deleterious effects have proved informative in identifying risk genes for early-onset diseases such as congenital heart disease (CHD). A number of statistical methods been proposed family-based studies or case/control to identify by screening more DNVs than expected chance Whole Exome Sequencing (WES) studies. However, the power is still limited cohorts thousands subjects. Under hypothesis that connected protein-protein interaction (PPI) networks are likely share...

10.1371/journal.pgen.1010252 article EN cc-by PLoS Genetics 2022-06-07

Alternative splicing is a crucial cellular process in eukaryotes, enabling the generation of multiple protein isoforms with diverse functions from single gene. To better understand impact alternative on structures, protein-protein interaction and human diseases, we developed ASpdb (https://biodataai.uth.edu/ASpdb/), comprehensive database integrating experimentally determined structures AlphaFold 2-predicted models for isoforms. includes over 3400 canonical isoforms, each represented by both...

10.1093/nar/gkae1018 article EN cc-by-nc Nucleic Acids Research 2024-11-12

Background Genome‐wide association studies (GWAS) have succeeded in identifying tens of thousands genetic variants associated with complex human traits during the past decade, however, they are still hampered by limited statistical power and difficulties biological interpretation. With recent progress expression quantitative trait loci (eQTL) studies, transcriptome‐wide (TWAS) provide a framework to test for gene‐trait associations integrating information from GWAS eQTL studies. Results In...

10.15302/j-qb-020-0228 article EN Quantitative Biology 2021-02-01

Abstract Recently polygenetic risk score (PRS) has been successfully used in the prediction of complex human diseases. Many studies incorporated internal information, such as effect size distribution, or external linkage disequilibrium, functional annotation, and pleiotropy among multiple diseases, to optimize performance PRS. To leverage on multiomics datasets, we developed a novel flexible transcriptional (TRS), which messenger RNA expression levels were imputed weighted for prediction. In...

10.1002/gepi.22424 article EN Genetic Epidemiology 2021-07-10

Recent studies have demonstrated that multiple early-onset diseases shared risk genes, based on findings from de novo mutations (DNMs). Therefore, we may leverage information one trait to improve statistical power identify genes for another trait. However, there are few methods can jointly analyze DNMs traits. In this study, develop a framework called M-DATA ( M ulti-trait De mutation A ssociation T est with nnotations) increase the of association analysis by integrating data correlated...

10.1371/journal.pgen.1009849 article EN cc-by PLoS Genetics 2021-11-04

Alternative splicing is an important cellular process in eukaryotes, altering pre-mRNA to yield multiple protein isoforms from a single gene. However, our understanding of the impact alternative events on structures currently constrained by lack sufficient structural data. To address this limitation, we employed AlphaFold 2, cutting-edge structure prediction tool, conduct comprehensive analysis for approximately 3,000 human genes, providing valuable insights into its structural. Our...

10.1101/2024.01.30.578053 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2024-02-01

Pregnancy at advanced maternal age is considered a risk factor for adverse maternal, fetal, and neonatal outcomes. Here we investigated whether could be associated with differences in the blood levels of newborn screening (NBS) markers inborn metabolic disorders on Recommended Universal Screening Panel (RUSP). Population-level NBS data from screen-negative singleton infants were examined, which included covariates such as gestational age, birth weight, collection, infant sex, parent-reported...

10.20944/preprints202311.1262.v1 preprint EN 2023-11-21

Pregnancy at an advanced maternal age is considered a risk factor for adverse maternal, fetal, and neonatal outcomes. Here we investigated whether could be associated with differences in the blood levels of newborn screening (NBS) markers inborn metabolic disorders on Recommended Universal Screening Panel (RUSP). Population-level NBS data from screen-negative singleton infants were examined, which included covariates such as collection, birth weight, gestational age, infant sex,...

10.3390/metabo14010005 article EN cc-by Metabolites 2023-12-20
Zhishan Chen Xingyi Guo Ran Tao Jeroen R. Huyghe Philip Law and 95 more Ceres Fernández‐Rozadilla Jie Ping Guochong Jia Jirong Long Chao Li Quanhu Shen Yuhan Xie Maria Timofeeva Minta Thomas Stephanie L. Schmit Virginia Díez‐Obrero Matthew A.M. Devall Ferrán Moratalla-Navarro Juan Fernández‐Tajes Claire Palles Kitty Sherwood Sarah Briggs Victoria Svinti Kevin Donnelly Susan M. Farrington James P. Blackmur P G Vaughan-Shaw Xiao‐Ou Shu Yingchang Lu Peter Broderick James B. Studd Tabitha A. Harrison David V. Conti Fredrick R. Schumacher Marilena Melas Gad Rennert Mireia Obón‐Santacana Vicente Martín Jae Hwan Oh Jeongseon Kim Sun Ha Jee Keum Ji Jung Sun-Seog Kweon Min‐Ho Shin Aesun Shin Yoon‐Ok Ahn Dong-Hyun Kim Isao Oze Wanqing Wen Keitaro Matsuo Koichi Matsuda Chizu Tanikawa Zefang Ren Yu‐Tang Gao Wei‐Hua Jia John L. Hopper Mark A. Jenkins Aung Ko Win Rish K. Pai Jane C. Figueiredo Robert W. Haile Steven Gallinger Michael O. Woods Polly A. Newcomb David Duggan Jeremy P. Cheadle Richard Kaplan Rachel Kerr David Kerr Iva Kirac Jan Böhm Jukka‐Pekka Mecklin Pekka Jousilahti Paul Knekt Lauri A. Aaltonen Harri Rissanen ­Eero Pukkala Johan G. Eriksson Tatiana Cajuso Ulrika A. Hänninen Johanna Kondelin Kimmo Palin Tomas Tanskanen Laura Renkonen‐Sinisalo Satu Männistö Demetrius Albanes Stephanie J. Weinstein Edward A. Ruiz‐Narváez Julie R. Palmer Daniel D. Buchanan Elizabeth A. Platz Kala Visvanathan Cornelia M. Ulrich Erin M. Siegel Stefanie Brezina Andrea Gsur Peter T. Campbell Jenny Chang‐Claude Michael Hoffmeister Hermann Brenner

10.17615/f3mg-7f39 article EN cc-by Carolina Digital Repository (University of North Carolina at Chapel Hill) 2024-04-26

Abstract Recent studies have demonstrated that multiple early-onset diseases shared risk genes, based on findings from de novo mutations (DNMs). Therefore, we may leverage information one trait to improve statistical power identify genes for another trait. However, there are few methods can jointly analyze DNMs traits. In this study, develop a framework called M-DATA ( M ulti-trait De mutation A ssociation T est with nnotations) increase the of association analysis by integrating data...

10.1101/2021.05.22.21257421 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2021-05-23

Abstract Ischemic stroke (IS) is a highly heritable trait. Genome-wide association studies have identified several commonly occurring susceptibility risk loci for this condition. However, there are limited data on the contribution of rare genetic variation to IS. We conducted whole-exome study IS in 152,058 UK Biobank participants (mean age 57, 6.8 [SD 8.0], 83,131 [54.7%] were females), including 1,777 cases 61.4 6.6], 666 [37.5%] females). performed single-variant analyses all variants and...

10.1101/2022.05.31.22275825 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2022-06-02

Abstract In the era of precision medicine, many biomarkers have been discovered to be associated with drug efficacy and safety responses, which can used for patient stratification response prediction. Due small sample size limited power randomized clinical studies, meta-analysis is usually conducted aggregate all available studies maximize identifying prognostic predictive biomarkers. Since data are already aggregated, it often challenging find an independent study replicate discoveries from...

10.1101/2022.12.08.22283210 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2022-12-09

Abstract De novo variants (DNVs) with deleterious effects have proved informative in identifying risk genes for early-onset diseases such as congenital heart disease (CHD). A number of statistical methods been proposed family-based studies or case/control to identify by screening more DNVs than expected chance Whole Exome Sequencing (WES) studies. However, the power is still limited cohorts thousands subjects. Under hypothesis that connected protein-protein interaction (PPI) networks are...

10.1101/2021.11.30.21267069 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2021-12-02
Coming Soon ...